Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 99.89% | 84.01% | 84.76% | 5.53% | 14.57% |
| Total Depreciation and Amortization | -15.38% | -6.15% | 0.00% | -28.73% | -50.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.11% | 123.91% | 261.66% | 104.44% | -29.80% |
| Change in Net Operating Assets | -127.23% | -105.78% | -220.38% | -132.45% | -128.27% |
| Cash from Operations | 31.10% | 29.26% | 19.61% | -343.00% | -329.52% |
| Capital Expenditure | -- | -507.14% | -135.71% | 57.58% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -666.63% | -524.93% | -382.10% | -230.93% | 185.86% |
| Cash from Investing | -666.84% | -525.42% | -382.46% | -230.44% | 185.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,359.33% | 451.13% | 493.12% | 783.33% | -10.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,359.33% | 451.13% | 493.12% | 783.33% | -10.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.57% | 65.24% | 8.66% | -429.51% | 298.67% |